The FDA has started a review of GSK’s five-in-one meningococcal vaccine, cueing up a decision in mid-February next year, as it tries to chase down a rival candidate from Pfizer cleared last year.
Trump’s Dressing Down of Zelensky Plays Into Putin’s War Aims President Vladimir Putin of Russia could prolong the fight in Ukraine after the public blowup between President Trump and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback